Attention is focusing on Omipalisib, which was newly discovered by Korean researchers as a candidate material for COVID-19.

In particular, as laboratory studies show that candidate substance is more than 200 times more effective than Veklury (Remdesivir), some are optimistic that it will be a "game changer" for the corona crisis. Some pharmaceutical industries are wary of expanding interpretation of anti-virus effects. Laboratory findings do not indicate actual clinical efficacy.

#Sb◆Ompalisib, new anti-cancer drug candidate for PI3K suppression mechanism

KAIST and Institut Pasteur Korea announced on the 8th that they have discovered Omipalisib as a candidate m